General Discussions

Click here to start a new discussion.

Genetic Testing and Inherited Increased Risk of Cancer

By: Charlotte Ference, LMSW The American Cancer Society estimates that 5%-10% of cancers are connected with mutations in the DNA that are inherited through generations.1 For millions of patie...

1 replies - Dec 12, 2019 2:07:26 am
Discussions - General Discussions

After Doughnut Hole Closure, Oral Anticancer Drug Costs Still Too High for Many

Stacie Dusetzina, PhD Studies show that cost is a factor in patient adherence to their oral anticancer medications, but the financial burden of oral chemotherapy drugs is projected to still be to...

5 replies - Nov 22, 2019 5:24:57 am
Discussions - General Discussions

FDA Approves Alpelisib for Metastatic Breast Cancer

The FDA has approved the PI3K inhibitor alpelisib (Piqray) for the treatment of postmenopausal women, and men, with HR-positive, HER2-negative, PIK3CA-mutated, advanced or metastatic breast ca...

1 replies - Nov 15, 2019 6:18:38 am
Discussions - General Discussions

Death With Dignity

Lisa Schulmeister, RN, MN, APRN-BC, OCN®, FAAN Editor-in-Chief OncLive Nursing Oncology Nursing Consultant, Adjunct Assistant Professor of Nursing Louisiana State Health Sc...

6 replies - Nov 11, 2019 6:57:10 am
Discussions - General Discussions

Expert Discusses Genetic Predisposition to Prostate Cancer in Racially Diverse Patient Populations

At the 2019 Prostate Cancer Consensus Conference, prostate cancer experts gathered along with genetic counseling experts to discuss the implementation of genetic testing for treating patients wit...

1 replies - Oct 31, 2019 9:39:58 am
Discussions - General Discussions

Expert Discusses the Safety of Vemurafenib

Vemurafenib (Zelboraf) is a safe treatment option for heavily pretreated patients with hairy cell leukemia (HCL) who have progressed on moxetumomab pasudotox (Lumoxiti), according to Agnieszka Ja...

1 replies - Oct 29, 2019 3:15:00 am
Discussions - General Discussions

Expert Discusses the Importance of Axillary Lymph Node Dissection

In a presentation at the 21st Annual Lynn Sage Breast Cancer symposium Andrea V. Barrio, MD, FACS, spoke on axillary management after neoadjuvant chemotherapy and addressing some of the challenge...

1 replies - Oct 27, 2019 2:52:58 pm
Discussions - General Discussions

Expert Discusses Challenges of Using CAR T-Cell Therapy to Treat Diffuse Large B-Cell Lymphoma

At the 2019 School of Hematological Oncology, OncLive®, a sister publication of Oncology Nursing News®, sat down with David G. Maloney, MD, PhD, medical director of cellular immunotherapy...

2 replies - Oct 01, 2019 11:58:44 am
Discussions - General Discussions

Next Page >>